Innate immunity and inflammation in ageing: a key for understanding age-related diseases.
Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, Caruso C. · 2005
Read Innate immunity and inflammation in ageing: a key for understanding age-related diseases. by Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, Caruso C. (2005) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1166571.txt.
Introduction
Licastro and colleagues argue that lifelong low-grade swelling is a key driver of age-related disease in this 2005 review. Swelling, called inflammation, is the immune system's answer to invasion by viruses or bacteria. It is not harmful in itself. Human immunity evolved to run for 40 or 50 years, but it must now stay active far longer.
That long activity breeds a chronic state that slowly damages organs, the authors say. Alzheimer disease, atherosclerosis, diabetes, muscle wasting, and cancer all have an important inflammatory part. People with pro-inflammatory genotypes, gene variants that fan swelling, age less successfully. Keeping swelling in check tracks with longer life. The review frames innate immunity, the body's first-line defence, as the key to understanding these diseases.
Catalog record
| CREATOR | Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, Caruso C. |
|---|---|
| YEAR | 2005 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 77 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Innate immunity and inflammation in ageing: a key for understanding age-related diseases By Federico Licastro, Giuseppina Candore, Domenico Lio, Elisa Porcellini, Giuseppina Colonna-Romano, Claudio Franceschi, Calogero Caruso Published in: Immunity & ageing : I & A DOI: 10.1186/1742-4933-2-8 ABSTRACT Abstract The process of maintaining life for the individual is a constant struggle to preserve his/her integrity. This can come at a price when immunity is involved, namely systemic inflammation. Inflammation is not per se a negative phenomenon: it is the response of the immune system to the invasion of viruses or bacteria and other pathogens. During evolution the human organism was set to live 40 or 50 years; today, however, the immune system must remain active for much a longer time. This very long activity leads to a chronic inflammation that slowly but inexorably damages one or several organs: this is a typical phenomenon linked to ageing and it is considered the major risk factor for age-related chronic diseases. Alzheimer's disease, atherosclerosis, diabetes and even sarcopenia and cancer, just to mention a few – have an important inflammatory component, though disease progression seems also dependent on the genetic background of individuals. Emerging evidence suggests that pro-inflammatory genotypes are related to unsuccessful ageing, and, reciprocally, controlling inflammatory status may allow a better chance of successful ageing. In other words, age-related diseases are "the price we pay" for a life-long active immune system: this system has also the potential to harm us later, as its fine tuning becomes compromised. Our immune system has evolved to control pathogens, so pro-inflammatory responses are likely to be evolutionarily programmed to resist fatal infections with pathogens aggressively. Thus, inflammatory genotypes are an important and necessary part of the normal host responses to pathogens in early life, but the overproduction of inflammatory molecules might also cause immune-related inflammatory diseases and eventually death later. Therefore, low responder genotypes involved in regulation of innate defence mechanisms, might better control inflammatory responses and age-related disease development, resulting in an increased chance of long life survival in a "permissive" environment with reduced pathogen load, medical care and increased quality of life. Keywords: Age-related diseases, Cytokine, Inflammation, Innate Immunity, Longevity INNATE IMMUNE SYSTEM The first line of immune defence mainly operates by detection of a broad range of molecular patterns foreign to mammalian tissues, called pathogen-associated molecular patterns that induce the activation of the innate immunity and inflammatory response [1]. The constitutive expression of a limited set of pattern recognition receptors by many cell types of the innate immunity does not require clonal expansion of specific cell populations. These germ cell-encoded proteins recognize microbial pathogens or ligands from damaged tissues based on shared molecular structures and induce host responses that localize the spread of infection and enhance systemic resistance to infection. Therefore, the expression of a limited number of highly active genes during the activation of innate immunity is able to induce rapid (minutes to hours) efficient defensive immune responses [2]. Several cell types contribute to innate immunity and the mononuclear phagocyte lineage plays a pivotal role in innate immunity. Monocytes, macrophages and their tissue-differentiated derivatives, such as microglia in the nervous system, express pattern recognition receptors, namely various scavenger and Toll-like receptors [3]. These receptors induce transmembrane signals that activate NF-kB and mitogen dependent protein kinase pathways [4]. Toll-like receptor activation also induces the expression of a wide number of genes encoding proteins, such as cytokines, with regulatory functions upon leukocyte activation and tissue inflammation [5]. Therefore, the capacity of each individual organism to regulate the activation of innate immunity and local inflammatory responses is crucial for initiating defensive action against pathogens, limiting tissue damage and enhancing fast recovery and tissue healing. THE INFLAMMATORY RESPONSE In response to cell injury elicited by trauma or infection the inflammatory response sets in, constituting a complex network of molecular and cellular interactions directed to facilitate a return to physiological homeostasis and tissue repair. The response is composed of both local events and a systemic activation mediated by cytokines. If tissue health is not restored or in response to stable low grade irritation, inflammation becomes a chronic condition that continuously damages the surrounding tissues. In fact, during chronic inflammatory immune responses, tissue injury and healing proceed simultaneously. The collateral damage caused by this type of inflammation usually accumulates slowly, sometimes asymptomatically for years but can eventually lead to severe tissue deterioration [6]. Cytokines are largely secreted molecules that act on the surrounding microenvironment by providing cell to cell signalling. Cytokines are components of a large, complex signalling network. The effects of cytokines on target cells may be inhibited or enhanced by other cytokines, hormones, and cytokine-receptor antagonists and circulating receptors. Tumor necrosis factor α (TNF-α), Interleukin-1 (IL-1) and IL-6 are the classical pro-inflammatory cytokines. Their ability to activate both local and systemic effects is well established. Locally, they contribute to the activation of the inflammatory cells and together with chemokines, which induce the expression of adhesion molecules, cause their local recruitment. When the causes of the inflammatory reaction are of a high intensity, the production of cytokines is increased and they are released in the circulation provoking the "acute phase response". On the other hand, "inhibitory" cytokines such as IL-10 damp down the activation of some effector functions of T lymphocytes and mononuclear phagocytes, by inhibiting the release of pro-inflammatory cytokines and therefore turning off the inflammatory processes [7,8]. The acute phase response e.g. leukocytosis, fever, somnelence, anorexia and acute phase proteins synthesis, such as C reactive protein (CRP) in the liver, is a highly conserved inflammatory response which is rapidly activated by infections or trauma via pattern recognition molecules. Acute phase protein concentration rapidly increases after infection, and their production is controlled primarily by IL-6- and IL-1-type cytokines. The acute phase proteins provide enhanced protection against microorganisms and modify inflammatory responses by affecting cell trafficking and mediator release. The more traditional view of acute phase proteins has extended beyond that of opsonization of microorganisms. Some acute phase proteins have anti-inflammatory effects while others have important effects on leukocyte activation and trafficking [9]. CRP, named for its capacity to precipitate the somatic C-polysaccharide of Streptococcus pneumoniae, was the first acute-phase protein to be described, and is an exquisitely sensitive systemic marker of inflammation and tissue damage. It is a member of the pentraxin family of plasma proteins, which are part of the lectin fold superfamily of calcium-dependent ligand-binding and lectin (carbohydrate-binding) proteins. In healthy blood donors, the median concentration of CRP is 0.8 mg/l, but following an acute-phase stimulus, values may increase 10 000-fold. In an apparently healthy population the median baseline value is slightly higher and tends to increase with age with females showing slightly higher circulating concentrations. In most, but not all diseases, the circulating value of CRP reflects on-going inflammation much more accurately than do other biochemical parameters of inflammation, such as plasma viscosity or the erythrocyte sedimentation rate [10]. INNATE IMMUNE SYSTEM DURING AGEING Age related changes in clonotypic immune system are well documented. For instance, involution of the thymus gland is an early feature of the immune reconfiguration and several age- related alterations of T or B cell compartments have been described [11-13]. Studies on age-associated changes of the innate